These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23509569)

  • 21. Postfracture care for older women: gaps between optimal care and actual care.
    Metge CJ; Leslie WD; Manness LJ; Yogendran M; Yuen CK; Kvern B;
    Can Fam Physician; 2008 Sep; 54(9):1270-6. PubMed ID: 18791104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines.
    Wang CC; Wu CH; Farley JF
    Ann Pharmacother; 2015 Sep; 49(9):995-1003. PubMed ID: 26041809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pharmacist-led pilot program to facilitate deprescribing in a primary care clinic.
    Clark CM; LaValley SA; Singh R; Mustafa E; Monte SV; Wahler RG
    J Am Pharm Assoc (2003); 2020; 60(1):105-111. PubMed ID: 31690514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of pharmacist clinical interventions in a Dutch hospital setting.
    Bosma L; Jansman FG; Franken AM; Harting JW; Van den Bemt PM
    Pharm World Sci; 2008 Jan; 30(1):31-8. PubMed ID: 17592752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacotherapy of osteoporosis in ambulatory practice and its pharmaceutical aspects].
    Baranovicová E; Luknárová N; Foltán V
    Ceska Slov Farm; 2001 Jul; 50(4):188-92. PubMed ID: 11475891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical decision and patient education of pharmacotherapy for osteoporosis].
    Hosoi T
    Nihon Rinsho; 2009 May; 67(5):909-13. PubMed ID: 19432108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of a pharmacotherapy/research rotation in a family medicine training program.
    Murphy JA; Shrader SR; Montooth AK
    Fam Med; 2008 Jun; 40(6):395-9. PubMed ID: 18773776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Building a pharmacist-managed pharmacotherapy medication therapy management practice.
    Schuh MJ; Crumb DJ; Dubois J
    Consult Pharm; 2011 Jun; 26(6):404-13. PubMed ID: 21628139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving prescribing practices: A pharmacist-led educational intervention for nurse practitioner students.
    Sabatino JA; Pruchnicki MC; Sevin AM; Barker E; Green CG; Porter K
    J Am Assoc Nurse Pract; 2017 May; 29(5):248-254. PubMed ID: 28213909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporosis risk screening for women in a community pharmacy.
    Liu Y; Nevins JC; Carruthers KM; Doucette WR; McDonough RP; Pan X
    J Am Pharm Assoc (2003); 2007; 47(4):521-6. PubMed ID: 17616501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center].
    Schwartzberg E; Livny S; Sterenberg A; Troitsa A; Oren M; Shani S
    Harefuah; 2003 Jan; 142(1):5-9, 80. PubMed ID: 12647481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the fracture risk assessment on patient and physician behavior in osteoporosis prevention.
    McConaha JL; Berdine HJ; Skomo ML; Laux RV; Higginbotham SK; O'Neil CK
    J Pharm Pract; 2014 Feb; 27(1):25-30. PubMed ID: 24108433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does a primary care practice pharmacist improve the timeliness and completion of medication management reviews?
    Freeman C; Cottrell WN; Kyle G; Williams I; Nissen L
    Int J Pharm Pract; 2012 Dec; 20(6):395-401. PubMed ID: 23134099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating a pharmacist into the general practice environment: opinions of pharmacist's, general practitioner's, health care consumer's, and practice manager's.
    Freeman C; Cottrell WN; Kyle G; Williams I; Nissen L
    BMC Health Serv Res; 2012 Aug; 12():229. PubMed ID: 22852792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An exploration of the role of pharmacists within general practice clinics: the protocol for the pharmacists in practice study (PIPS).
    Tan E; Stewart K; Elliott RA; George J
    BMC Health Serv Res; 2012 Aug; 12():246. PubMed ID: 22876813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autonomy begets adherence: decisions to start and persist with osteoporosis treatment after group medical consultation.
    Wilton-Clark MS; Feasel AL; Kline GA; Billington EO
    Arch Osteoporos; 2020 Sep; 15(1):138. PubMed ID: 32888079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Family physician perceptions of barriers and enablers to integrating a co-located clinical pharmacist in a medical clinic: A qualitative study.
    Medgyesi N; Reardon J; Leung L; Min J; Yuen J
    J Am Pharm Assoc (2003); 2020; 60(6):1021-1028. PubMed ID: 32900606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacoeconomic assessment of clinical pharmacist interventions for patients with moderate to severe asthma in outpatient clinics : experience in taiwan.
    Chan AL; Wang HY
    Clin Drug Investig; 2004; 24(10):603-9. PubMed ID: 17523722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the pharmacist in optimizing pharmacotherapy in older people.
    Spinewine A; Fialová D; Byrne S
    Drugs Aging; 2012 Jun; 29(6):495-510. PubMed ID: 22642783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of an osteoporosis intervention among older adults residing in assisted living facilities.
    Setter SM; Corbett CF; Higgins TC; Sclar DA; Viren FK
    Consult Pharm; 2005 May; 20(5):416-23. PubMed ID: 16548639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.